Qbrelis Solution
Product Images NDC 52652-3001
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Qbrelis (NDC 52652-3001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Azurity Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (Bottle Label)
This is a description of a medication with the identifier NDC 52652-3001-1. The medication contains lisinopril, with a concentration of 1 mg/mL in a 150 mL oral solution. The usual dose is not provided, so one must refer to the prescribing information. It is suggested to store the medication at room temperature (20°-25°C or 68°-77°F) and to keep the container tightly closed. The medication should be kept out of the reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.